Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Pfizer 15.034, Moderna 0.145.
Pfizer vs Moderna: Revenue Comparison
Pfizer (PFE) and Moderna (MRNA) are peers in Vaccines. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $145M for Moderna. Pfizer leads on revenue.
Pfizer's gross margin is 72.8% versus 35.9% for Moderna. Pfizer's net margin is -1.6% versus -539.3% for Moderna.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Moderna.| Metric | Pfizer | Moderna |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.03B | $145.00M |
| Cost of Revenue | $4.09B | $93.00M |
| Gross Profit | $10.94B | $52.00M |
| Operating Income | $4.71B | $-815.00M |
| Net Income | $-246.00M | $-782.00M |
| R&D Expense | $2.81B | $651.00M |
| Earnings Per Share | -$0.04 | -$1.96 |
| Gross Margin | 72.8% | 35.9% |
| Operating Margin | 31.3% | -562.1% |
| Net Profit Margin | -1.6% | -539.3% |
| Free Cash Flow | $302.00M | $-563.00M |
| Cumulative Free Cash Flow | $356.70B | $7.37B |
| Operating Cash Flow | $835.00M | $-526.00M |
| Cash & Equivalents | $976.00M | $1.72B |